Gemphire Therapeutics Inc buy melinda
Start price
29.06.17
/
50%
?293.83
Target price
18.07.17
€383.35
Performance (%)
24.92%
End price
18.07.17
€367.05
Summary
This prediction ended on 18.07.17 with a price of €367.05. The prediction had a final performance of 24.92%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Gemphire Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by melinda for this prediction
In the thread Gemphire Therapeutics Inc diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten

(Vom Mitglied beendet)
Stopped prediction by melinda for Gemphire Therapeutics Inc
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?27.75
14.11.18
14.11.18
€31.57
04.12.18
04.12.18
12.14%
04.12.18
04.12.18
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?221.67
23.10.17
23.10.17
€248.05
26.12.17
26.12.17
-16.79%
26.12.17
26.12.17
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?245.75
23.10.17
23.10.17
€275.00
26.12.17
26.12.17
-16.79%
26.12.17
26.12.17
Gemphire Therapeutics Inc
Start price
Target price
Perf. (%)
?325.75
29.06.17
29.06.17
€425.00
18.07.17
18.07.17
24.92%
18.07.17
18.07.17


